Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|
Net Debt | $76.7M | $347.4M | $10.7M | $370.2M | $432.2M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, LifeStance Health Group, Inc.'s last 12-month Net Debt is $384.1M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, LifeStance Health Group, Inc.'s Net Debt growth was (13.4%). The average annual Net Debt growth rates for LifeStance Health Group, Inc. have been 11.1% over the past three years, N/A over the past five years.
Over the last year, LifeStance Health Group, Inc.'s Net Debt growth was (13.4%), which is lower than industry growth of (0.3%). It indicates that LifeStance Health Group, Inc.'s Net Debt growth is Good.